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The past 25 years have witnessed the field of molecular
pathologyevolving froman impreciselydefineddiscipline
to a firmly established medical subspecialty that plays an
essential role in patient care. During this time, the train-
ing, certification, and licensure requirements for directing
and performing testing in a molecular pathology or mo-
lecular diagnostics laboratoryhave becomebetter defined.
The purpose of this document is to describe the various
board certifications available to individuals seeking certi-
fication in molecular diagnostics at the level of laboratory
director, supervisor, or technologist. Several national or-
ganizations offer certification in molecular pathology or
molecular diagnostics for doctoral-level clinical scientists
to function as the director of a molecular diagnostics lab-
oratory. Furthermore, 12 states and Puerto Rico require
licensing of medical technologists, including those work-
ing inmolecular diagnostic laboratories. The information
provided here updates a 2002 document by the Training
and Education Committee of the Association for Molec-
ular Pathology and has been expanded to include certi-
fication and licensing requirements for laboratory
technologists. (J Mol Diagn 2012, 14:541–549; http://dx.
doi.org/10.1016/j.jmoldx.2012.05.004)
The present document is an update to “Certification in Mo-
lecular Pathology in the United States,” by the Training andEducation Committee of the Association for Molecular Pa-
thology, published in 2002.1 This update includes certifica-
tion and licensing requirements for laboratory technologists.
Overview of Certification Routes in
Molecular Diagnostics
The qualifications of laboratory director for a laboratory
that performs high complexity testing are defined in sub-
part M, section 493.1443 of current regulations under
Clinical Laboratory Improvement Amendments (CLIA) of
1988 (http://www.cdc.gov/clia/regs/subpart_m.aspx#
493.1443). Licensed physicians who are certified in an-
atomic and/or clinical pathology by the American Board
of Pathology (ABP) or anatomic pathology and/or labora-
tory medicine by the American Osteopathic Board of
Pathology (AOBP) meet these qualification standards. In
addition, licensed physicians with either 1 year of labo-
ratory training during medical residency [eg, physicians
certified in hematology or medical oncology by the Amer-
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years of experience directing or supervising high com-
plexity testing also meet these qualification standards.
Doctoral-level clinical scientists also satisfy the re-
quirements for laboratory director, provided they are
certified by a board approved by the U.S. Department
of Health and Human Services (HHS) (Tables 1 and 2).
Licensure must be by the state in which the laboratory
is located.
The subspecialty of molecular diagnostics has grown
dramatically in both scope and scale over recent years.
Recognizing the need to prepare future directors of mo-
lecular diagnostic laboratories, Molecular Genetic Pathol-
ogy (MGP) fellowship training programs accredited by
the Accreditation Council of Graduate Medical Education
(ACGME) recently became available for eligible medical
doctors. Board certification in MGP is offered jointly by
the ABP and the American Board of Medical Genetics
(ABMG). Although MGP certification is not a CLIA re-
Table 1. Boards Offering Certification in Molecular Diagnostics o
Agency (website) Certification designation
ABP (http://www.abpath.org) or
ABMG (http://www.abmg.org)
MGP
ABMG (http://www.abmg.org) CMG
ABB (http://www.aab.org) HCLD(ABB), BCLD(ABB),
TS(ABB)
ABCC
(http://www.abclinchem.org)
DABCC
ASCP BOC (http://www.
ascp.org/Board-of-Certification)
MB(ASCP)
AAB (http://www.aab.org) MT(AAB), MLT(AAB)
*Applicants schedule an examination at a Pearson Professional Cente
AAB, American Association of Bioanalysts; ABCC, American Board of
Board of Bioanalysis; ABP, American Board of Pathology; ASCP, Americ
CE, continuing education; CEU, continuing education units; CMG, Clin
Chemistry; HCLD, High Complexity Laboratory Director; MB, Molecular B
MOC, maintenance of certification; MT, Medical Technologist; TS, Techn
Table 2. Educational Requirements for Certificates in Molecular
Degree and laboratory role
M.D., D.O.
Director
M.D., D.O., or Ph.D.
Director
Director
Director
Director
M.D., D.O., Ph.D., master, or baccalaureate‡
Supervisor
Supervisor
Supervisor
Associate degree‡ or clinical laboratory training program
Technologist
*MGP certification is not required to function as a Laboratory Director
†HCLD and BCLD requirements for Laboratory Director vary by stat
professional regulation.
‡MT(AAB) certification is available to individuals with an associate degree.
CLIA, Clinical Laboratory Improvement Amendments (1988); the remaining aquirement for laboratory director, it provides the oppor-
tunity to gain additional experience and ability in direct-
ing a molecular diagnostics laboratory. Recognizing that
the distinctions between molecular pathology and molec-
ular diagnostics are imprecise, the two terms are used
interchangeably in this document; a distinction is made
only when necessary to comply with the wording used by
specific certification agencies.
Of the HHS-approved boards that offer certification for
doctoral-level clinical scientists, the ABMG, the American
Board of Bioanalysis (ABB), and the American Board of
Clinical Chemistry (ABCC) provide specific certification in
molecular diagnostics for individuals with a Ph.D. degree.
For non-director-level laboratory professionals, such as
laboratory supervisors and technologists, the ABB, the
American Society for Clinical Pathology (ASCP), and the
American Association of Bioanalysts (AAB) also offer cer-
tification in molecular diagnostics.
cular Pathology
ination frequency
Certificate
duration CE requirements
al 10 years MOC program required
nial 10 years MOC program required
iannual 1 year 24 contact hours (2.4 CEU)
of acceptable CE every
2 years
iannual 2 years 50 contact hours (5.0 CEU)
of participation every 2
years in an organized CE
experience
* 3 years MOC program participation
required
times per year 1 year CE optional
//www.pearsonvue.com/ascp).
Chemistry; ABMG, American Board of Medical Genetics, ABB, American
ety for Clinical Chemistry; BCLD, Bioanalyst Clinical Laboratory Director;
ecular Genetics; DABCC, Diplomate of the American Board of Clinical
GP, Molecular Genetic Pathology; MLT, Medical Laboratory Technician;
ervisor.
stics
rtification designation
(certifying board)
Satisfy CLIA requirements for
laboratory director?
MGP (ABP/ABMG) Not applicable*
CMG (ABMG) Yes
DABCC (ABCC) Yes
HCLD (ABB) Yes†
BCLD (ABB) Yes†
TS (ABB) No
MB (ASCP) No
MT (AAB)‡ No
MLT (AAB) No
iduals should consult the particular state’s department of health and/orr Mole
Exam
Annu
Bien
Sem
Sem
Open
Five
r (http:
Clinical
an Soci
ical MolDiagno
Ce
.
e. Indivbbreviations are as for Table 1.
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JMD November 2012, Vol. 14, No. 6Finally, the American Society for Histocompatibility and
Immunogenetics (ASHI; http://www.ashi-hla.org) and the
ABB offer various types of certification in histocompatibility
and immunogenetics. These specialties make exten-
sive use of molecular diagnostic reagents and tech-
niques and are mentioned here for the benefit of indi-
viduals interested in learning more about certification
options in this area.
Medical Doctors: Certification in Molecular
Diagnostics
American Board of Pathology and American
Board of Medical Genetics
Certification in MGP is available from the ABP and the
ABMG to physicians who have primary certification from
one of those boards. These professional organizations co-
operatively function to determine the standards and content
of the MGP subspecialty examination and to certify the
qualifications of the applicants. Accreditation of MGP train-
ing programs began in 2002. Applicants must complete at
least 1 year of MGP training in an ACGME-accredited fel-
lowship program (http://www.acgme.org/adspublic).
MGP training programs are a joint function of the de-
partments of pathology and the departments and/or divi-
sions of medical genetics at the participating institutions.
MGP training programs are structured to provide appli-
cants with a functional understanding of the molecular
principles and technologies used in the diagnosis, man-
agement, and treatment of Mendelian genetic disorders,
neoplasia, infectious diseases, histocompatibility, and
disorders of human development.
Eligibility
Pathologist applicants seeking certification in MGP
from the ABP must be certified in anatomic pathology
and/or clinical pathology by the ABP and have completed
an ACGME-accredited MGP fellowship program. Certifi-
cation in MGP via the ABMG is available to physicians
with primary certification by the ABMG in clinical genetics
who have completed 1 year of training in an ACGME-
accredited MGP fellowship program. Individuals apply-
ing for MGP certification must hold a currently valid, full,
and unrestricted state medical license to practice medi-
cine or osteopathy in the United States or Canada. Ap-
plicants are required to complete all certification require-
ments within 5 years from completion of their training, or
within 5 years from the date of their primary certification,
whichever is later. Once an applicant is qualified by the
ABP or ABMG, he or she is permitted to take the MGP
examination a maximum of five times.
Examination
The first MGP examination was offered in 2001 and
examinations were given every 2 years until 2011. As of
2011, the MGP examination is offered annually. The MGPsubspecialty examination is a 1-day, computer-based
examination consisting of 300 questions. The examina-
tion is divided into a written section (100 questions) and
a practical section (200 questions). All questions are
multiple choice, and applicants must pass both the writ-
ten and practical sections to pass the MGP examination.
During the 2007 and 2009 MGP examination cycles, a
total of 106 individuals took the MGP examination for the
first time. Before 2007, individuals were permitted to take
the MGP examination without completing a 1-year
ACGME-accredited MGP fellowship by documenting suf-
ficient experience in MGP (the so-called experience
pathway). Beginning in 2007, all applicants are required
to complete at least 1 year of training in an ACGME-
accredited MGP fellowship. Individuals applying for the
MGP subspecialty examination must complete their train-
ing by October 1 of the year of application. To demon-
strate sufficient competencies for the MGP subspecialty,
applicants are required to submit a logbook documenting
their role and level of participation in 150 clinical cases
(http://www.abpath.org/FormsApps.htm).
Maintenance of Certification
The ABP began issuing time-limited certificates in
2006, and consequently ABP certification expires on De-
cember 31 of the 10th year after issuance of the original
certification. In addition, individuals who passed their
primary certification examination in 2006 or later are re-
quired to participate in the maintenance of certification
(MOC) process to maintain their board certification (http://
www.abpath.org/MOCIndex.htm). MOC was instituted as
part of a growing focus on quality health care in the
United States and provides a mechanism for an indi-
vidual to demonstrate his or her commitment to quality
patient care, quality improvement, and professional
development. MOC is a 10-year process beginning
immediately after board certification is obtained from
the ABP. Requirements for MOC are divided into four
general areas: Part 1, evidence of professional stand-
ing; Part 2, evidence of commitment for lifelong learn-
ing and involvement in periodic self-assessment; Part
3, evidence of cognitive expertise; and Part 4, evi-
dence of successful evaluation of performance in prac-
tice. Each of these main areas has specific require-
ments that must be satisfied and documented at 2-year
checkpoints throughout the 10-year MOC cycle. MGP
fellowship training in an ACGME-accredited fellowship
program satisfies the Part 2 and Part 4 requirements for
a 2-year period. During year 8 of the 10-year cycle, an
MOC examination must be satisfactorily completed.
The ABP recognizes the breadth and scope of pathol-
ogy practice and consequently plans to offer a 150-
question MGP MOC examination.
Medical doctors are eligible for certification in molec-
ular diagnostics by the ABMG, ABCC, and ABB, which is
also open to doctoral-level clinical scientists, as de-
scribed below.
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in Molecular Diagnostics
American Board of Medical Genetics
The ABMG is recognized by the American Board of Med-
ical Specialties and certifies individuals who apply genet-
ics to medical care in several specialties: clinical genet-
ics, clinical biochemical genetics, clinical cytogenetics,
and clinical molecular genetics (http://www.abmg.org/
pages/training_options.shtml). The ABMG clinical molec-
ular genetics (CMG) specialty focuses on molecular dis-
covery of and laboratory testing for mutations associated
with human disease.
Eligibility
CMG fellowship programs accredited by the ABMG
require a minimum of 24 months of training. Trainees
must hold either an M.D. or a Ph.D. degree (or the equiv-
alent) in genetics, molecular biology, or a related biolog-
ical field. Individuals who earned an M.D. or Ph.D. out-
side the United States or Canada must have the degree
reviewed by the ABMG Credentials Committee (http://
www.abmg.org/2011/cert_forcredential.shtml) before en-
tering a training program. In addition to the educational
requirements, an online logbook documenting the appli-
cant’s direct and meaningful involvement with specimen
processing, analysis, and interpretation of 150 laboratory
specimens must be submitted to the ABMG.
Examination
TheCMGexamination is offered annually at an examination
center managed by Prometric (Baltimore, MD) and consists of
two parts: a 3-hour general examination and a 2.5-hour CMG
specialty examination. Both parts consist of multiple choice
questions, and both parts of the examination must be passed
on the same test date for certification. Applicants who do not
pass the examination after three consecutive examination cy-
cles are required to complete an additional 24 months of
ABMG-accredited CMG postdoctoral training.
Maintenance of Certification
Examinees who pass both portions of the certification
examination are diplomates of the ABMG for a 10-year
period. Diplomates certified in 1993 or later are required to
participate in the four-part MOC program (http://www.
abmg.org/pages/maint_definitions.shtml).
American Board of Clinical Chemistry
Founded in 1950, the American Board of Clinical Chemistry
(ABCC) was established to certify individuals holding Ph.D.
degrees to serve as clinical laboratory directors. The ABCC
offers certification in Molecular Diagnostics, as well as a
number of other clinical science disciplines. Persons hold-
ing a valid Certificate of Qualification issued by the ABCCare entitled to use the designation Diplomate of the Ameri-
can Board of Clinical Chemistry and the initials DABCC.
Certification by the ABCC satisfies the CLIA 1988 regula-
tions to serve as the director of a high complexity clinical
laboratory and clinical consultant in laboratory medicine.
Eligibility
Applicants must possess an earned Ph.D. or an equiva-
lent doctoral degree in biochemistry, molecular biology, or
another of the natural sciences, or an M.D. degree from an
appropriately accredited university or college acceptable to
the Board. In addition, applicants must have satisfactorily
completed a minimum of 30 semester hours (or equivalent)
in undergraduate and/or graduate level courses in bio-
chemistry, molecular biology, or related fields taken at insti-
tutions acceptable to the Board. Hands-on laboratory re-
search experience in molecular biology may be substituted
for coursework if the applicant’s personal experience in the
laboratory is documented by a laboratory director, with 1 full
year of laboratory work equated to 10 semester hours of
coursework. Applicants with education obtained at institu-
tions outside the United States or Canada must, at their
expense, have their credentials evaluated by the Interna-
tional Education Research Foundation (http://www.ierf.org)
or an acceptable equivalent (http://www.abclinchem.org/
geninfo/Pages/cred_eval.aspx).
Before admission to examination, the applicant must
demonstrate 5 years of full-time (or equivalent part-time)
diverse professional experience in clinical molecular di-
agnostics. The experience must be obtained subsequent
to conferral of the doctoral degree and in laboratories or
institutions maintaining standards in molecular diagnos-
tics that are acceptable to the Board. Exceptions to these
professional requirements may be made if, before admis-
sion to examination, the applicant has completed 2 or
more years of full-time (or equivalent part-time) diverse
professional experience in clinical molecular diagnostics
and has successfully completed requirements for diplo-
mate status from one of these boards: the ABCC, ABMG,
ABP, American Board of Medical Microbiology (ABMM),
American Board of Medical Laboratory Immunology (AB-
MLI), or American Board of Histocompatibility and Immuno-
genetics (ABHI). Applicants from or graduates of postdoc-
toral training programs accredited by the Commission for
Accreditation in Clinical Chemistry (http://www.comacc.org/
Pages/default.aspx) who have passed the ABCC examina-
tion in either clinical chemistry or toxicological chemistry
may be admitted to the molecular diagnostics examination
on documentation of 1 year of focused experience in mo-
lecular diagnostics.
Examination
Applicants must successfully pass the ABCC Molecular
Diagnostics examination for DABCC certification. The multiple
choice, 3-hour examination is offered twice per year. The ex-
amination tests knowledge of inherited disease testing, infec-
tious disease testing, identity testing, oncology, pharmacoge-
netics, and general laboratory principles.
experie
s.asp).
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As of January 1, 2004, Diplomates of the ABCC must
document 50 contact hours of continuing education
credit every 2 years to maintain listing in the directory of
active diplomates.
American Board of Bioanalysis
Certification by the ABB is based on an individual’s educa-
tion, experience, and knowledge of the field in which the
certification is granted. Three certifications in Molecular Di-
agnostics are offered by the ABB: Technical Supervisor
(TS), Bioanalyst Clinical Laboratory Director (BCLD), and
High Complexity Clinical Laboratory Director (HCLD). Both
BCLD and HCLD certifications satisfy CLIA 1988 require-
ments for laboratory director in most states.
Eligibility
Eligibility criteria for BCLD and HCLD certification are
listed in Table 3.
Examination
Examination requirements for BCLD and HCLD certifi-
cation are listed in Table 3.
Maintenance of Certification
To maintain their ABB certification, BCLD and HCLD
laboratory directors are required to participate in the Pro-
fessional Education Enrichment Renewal program, which
consists of 24 contact hours (2.4 CEU) of acceptable
Table 3. American Board of Bioanalysis Certification Standards f
Clinical Laboratory Director (HCLD)
BCLD
Eligibility (Ph.D.)* Ph.D. in chemical, physical,
science from an accredite
recognized by the U.S. D
Education and successfu
of 32 semester hours in c
biological sciences accep
board
Eligibility (M.D., D.O., D.P.M.,
or equivalent)*
Licensed to practice medic
Experience 4 years of experience in the
a clinical laboratory at the
experience in the 10-year
or director of high comple
Examination Pass an ABB examination in
knowledge and in at leas
the clinical laboratory disc
chemistry, diagnostic imm
hematology, microbiology
health microbiology, and
diagnostics
*All degrees received outside the United States must be evaluated fo
http://www.aab.org/aab/Equivalency_Evaluations.asp.
†Effective January 1, 2012, ABB will accept up to 2 years of alternative
General Regulations, Rule 17 (http://www.aab.org/aab/General_Regulationcontinuing education every 2 years.Supervisors and Technologists: Certification
in Molecular Diagnostics
American Board of Bioanalysis
The ABB offers TS certification in molecular diagnostics.
The TS(ABB) designation is for individuals who are respon-
sible for the technical and scientific oversight of a laboratory
performing high complexity testing, but who do not fulfill
CLIA 1988 requirements for laboratory director.
Eligibility
Eligibility criteria for TS(ABB) certification are listed in
Table 4.
Examination
TS applicants must pass an ABB examination in molecular
diagnostics, but are not required to take the general knowl-
edge examination that is required for director applicants.
Maintenance of Certification
Supervisors are required to participate in the Profes-
sional Education Enrichment Renewal program to main-
tain their ABB certification; this program consists of 24
contact hours (2.4 CEU) of acceptable continuing edu-
cation every 2 years.
American Society for Clinical Pathology Board
of Certification
The American Society for Clinical Pathology Board of
Registry (ASCP BOR) established Molecular Pathology
nalyst Clinical Laboratory Director (BCLD) and High Complexity
HCLD
logical
tution
ent of
letion
ry or
to the
Either i) meet the eligibility described for BCLD or
ii) meet the qualifications as a Laboratory
Director of a laboratory performing high
complexity testing under the CLIA 1988
regulations, Subpart M, Section 493.1443 (http://
wwwn.cdc.gov/clia/regs/subpart_m.aspx#493.1443)
t least one (1) state in the United States
ar period prior to application date on human specimens in
um level of medical technologist, including: 2 years of
prior to application date must be at the level of supervisor
sting†
ral
(3) of
:
y,
lic
lar
Pass an ABB examination in general knowledge
and in at least one (1) the clinical laboratory
disciplines described (eg, molecular
diagnostics)
lency by an agency acceptable to the ABB; a current list is available at
nce to meet the 4-year experience requirement; see examples under ABBor Bioa
or bio
d insti
epartm
l comp
hemist
table
ine in a
10-ye
minim
period
xity te
gene
t three
iplines
unolog
or pub
molecu
r equivacertification as MP(ASCP) in 2003. On October 23,
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JMD November 2012, Vol. 14, No. 6Table 4. Eligibility Requirements for Certification in Molecular Diagnostics for Medical Technologists by the American Board of
Bioanalysts (ABB), American Society of Clinical Pathology (ASCP), and the American Association of Bioanalysis (AAB)
Option TS(ABB) MB(ASCP) MT(AAB) MLT(AAB)*
Applicants must meet one of the following requirements
1 Doctoral degree from an
accredited institution in a
chemical, physical,
biological or clinical
laboratory science or
medical technology
Both baccalaureate degree
and ASCP certification as a
technologist
Doctoral, master’s, or baccalaureate
degree from an accredited
institution, or the equivalent, with a
major in a chemical, physical,
biological, or clinical laboratory
science or medical technology
Successful completion of a
clinical laboratory training
program approved or
accredited by an
organization approved by
the HHS
2 Doctor of medicine or doctor
of osteopathy licensed to
practice medicine or
osteopathy
Both baccalaureate degree,
including courses in the
biological sciences,
chemistry, and
mathematics, and
completion of a NACCLS
diagnostic molecular
science program within the
past five (5) years
Associate degree or associate of
applied science degree with a
major in a laboratory science or
medical technology
Associate degree (or
equivalent) in a
laboratory science, or
medical laboratory
technology, from an
accredited institution†
3 Master’s degree from an
accredited institution in a
chemical, physical,
biological, or clinical
laboratory science or
medical technology
Baccalaureate degree with a
major in biological sciences
or chemistry, or with a
combination of 30 semester
hours (or 45 quarter hours)
of biology, chemistry, and/
or medical sciences
At least 60 semester hours, or
equivalent, from an accredited
institution including either 24 hours
of medical laboratory technology
courses or 24 semester hours of
science courses (6 semester
hours of chemistry, 6 semester
hours of biology, and 12 semester
hours of chemistry, biology or
medical laboratory technology)
Successful completion of
an official U.S. military
medical laboratory
procedures course of at
least 50 weeks duration,
earning the Military
Occupational Specialty of
Medical Laboratory
Specialist (Laboratory
Technician)
4 Bachelor’s degree from an
accredited institution in a
chemical, physical or
biological science or
medical technology
Graduate degree in
chemistry, biology,
immunology, microbiology,
allied health, clinical
laboratory sciences, or an
appropriately related field
Qualify as a technologist under the
revised Medicare/CLIA ’67
regulations‡
Five (5) years of full-time
clinical laboratory
experience (in the
applicable disciplines)
acceptable to the AAB
Board of Registry
5 A combination of
i) certification as a
POLT(AAB), ii) four (4)
years of acceptable
clinical laboratory
experience (in the
applicable disciplines),
and iii) 6 CEUs
Additional laboratory training requirements
For option 1 or 2: At least
one (1) year of relevant
experience§
For option 3: At least two
(2) years of relevant
experience§
For option 4: At least four
(4) years of relevant
experience§
For option 3: One (1) year of
full-time experience in a
molecular biology
laboratory in the United
States or Canada or in an
accredited laboratory¶
For option 4: Six (6) months of
clinical laboratory
experience in molecular
diagnostics in an
accredited laboratory¶
Either completion of a clinical laboratory training program
approved or accredited by an accrediting agency approved by
the HHS (eg, ABHES, NAACLS) or at least three (3) months of
documented laboratory training in each specialty in which the
individual performs high complexity testing
*Requirements differ for applicants seeking certification in California and include the added requirement of at least 60 semester hours from an
accredited college or university, of which at least 36 units are in physical and biological sciences with an emphasis on applied clinical science and include
6 semester hours of biology and 6 of chemistry. Full detail is available at (http://www.aab.org/aab/Application_MLT_California.asp).
†For the AAB, the equivalent of an associate degree is defined as 60 semester hours, of which 24 semester hours are either medical laboratory
technology courses or 6 semester hours of chemistry, 6 semester hours of biology, and 12 semester hours of courses in chemistry, biology, or medical
laboratory technology in any combination.
‡42 CFR 493.1433, published on March 14, 1990 (55 FR 9538).
§For the ABB, “relevant experience” includes clinical laboratory training or experience within the 10 years immediately prior to the application date on
human specimens in high complexity testing within the specialty.
¶For the ASCP, an “accredited laboratory” is one accredited by a CMS-approved accrediting organization (http://www.cms.gov/Regulations-and-
Guidance/Legislation/CLIA/Accreditation_Organizations_and_Exempt_States.html).
ABHES, Accrediting Bureau of Health Education Schools; CMS, U.S. Centers for Medicare and Medicaid Services; HHS, U.S. Departmentof Health and Human Services; NAACLS, National Accrediting Agency for Clinical Laboratory Sciences; POLT, Physician Office Laboratory
Technician.
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Agency for Laboratory Personnel (NCA) merged and
formed a single certification agency for medical labo-
ratory professionals. The resulting agency is called the
American Society for Clinical Pathology Board of Cer-
tification (ASCP BOC); the NCA dissolved as a corpo-
ration at that time. Before this merger, each agency
offered certification in molecular pathology or molecu-
lar biology. The ASCP BOR offered MP(ASCP) certifi-
cation, and the NCA offered certification as a Clinical
Laboratory Specialist in Molecular Biology [CLSp
(MB)]. At the time of the merger, it was decided to use
the designation Molecular Biology (MB) for certifica-
tion. The new designation adopted by the ASCP BOC is
MB(ASCP)CM; the CM superscript is used to designate
those who recertify voluntarily (see below, under Main-
tenance of Certification).
Eligibility
Eligibility criteria for MB(ASCP) certification are listed
in Table 4.
Examination
Applicants must successfully pass the MB(ASCP) cer-
tification examination. The examination is divided into
four subtests: molecular science (25% to 30%), molecu-
lar techniques (35% to 40%), laboratory operations (15%
to 20%), and applications of molecular testing (15% to
20%). A total score of 400 points is required to pass the
examination.
Maintenance of Certification
A Certification Maintenance Program (CMP) is re-
quired for all individuals newly certified as MB(ASCP)
since January 1, 2004, and for all active NCA certificants
who were not ASCP-certified before January 1, 2004.
Certificants must recertify every 3 years. Regarding the
designation of the certification, several scenarios existed
after the merger. First, individuals certified by the ASCP
BOR before January 1, 2004, have lifetime certification
and continue under the previous ASCP BOR designation
[MP(ASCP)], unless they elect for voluntary recertifica-
tion, in which case they are permitted to append the CM
superscript to their designation [MP(ASCP)CM]. Second,
individuals certified after January 1, 2004, are required
to recertify every 3 years by documenting continuing
education activities in the CMP, leading to the
MB(ASCP)CM designation. Failure to recertify leads to
loss of certification. Third, individuals certified by the
NCA at any time are required to recertify, because
recertification is one of the founding principles of the
NCA. Individuals with NCA certification status were trans-
ferred to the ASCP BOC database and received new
designations [MB(ASCP)CM]. Finally, individuals with
NCA certification who did not continue to recertify are
not considered to be certified, but have the option at
any time to participate in the recertification program,
which would then reinstate the original ASCP BORdesignation as MB(ASCP), provided they continue to
recertify every 3 years.
American Association of Bioanalysts Board
of Registry
The AAB Board of Registry (ABOR; http://www.aab.org/
aab/AAB_Board_of_Registry.asp) is an independent cre-
dentialing agency organized in 1962 that functions to
identify individuals who satisfy the requirements for cer-
tification as Medical Technologist MT(AAB) or Medical
Laboratory Technician MLT(AAB). The MT(AAB) and
MLT(AAB) certification examinations satisfy licensing re-
quirements for 11 of the 12 states (Table 5) that require
laboratory technologists or laboratory technicians to pass
certifying or licensure examinations; New York is the ex-
ception. MT(AAB) certification is offered in one or more of
the following eight disciplines: chemistry, hematology,
immunology, immunohematology, microbiology, androl-
ogy, embryology, and molecular diagnostics. Generalist
certification is also offered for both MT(AAB) and ML-
T(AAB), covering chemistry, hematology, immunology,
immunohematology, and microbiology. The major differ-
ences between the MT(AAB) and MLT(AAB) are respon-
sibility and supervisory roles in the laboratory; those with
MT(AAB) certification may perform high complexity pro-
cedures with minimal supervision; those with MLT(AAB)
certification perform waived and moderately complex
clinical laboratory procedures under the supervision of a
laboratory director, supervisor, or MT(AAB) technologist.
Eligibility
Eligibility criteria for ABOR certification are listed in
Table 4.
Examination
The MT(AAB) examinations are offered in two formats: a
discipline-specific examination or a Generalist examination.
Applicants taking the MT(AAB) certification examination by
discipline must successfully pass an examination in basic
knowledge and an examination in at least one discipline.
Applicants taking either the MT(AAB) or MLT(AAB) Gener-
alist certification examinations must successfully pass an
examination in basic knowledge and examinations in all of
the following individual disciplines: chemistry, hematology,
immunology, immunohematology, and microbiology. Appli-
cants who take the Generalist examination are required to
meet a minimum score in each of the disciplines, as well as
a minimum overall score. Both examinations were offered
five times in 2011.
Maintenance of Certification
All individuals certified by the AAB Board of Registry are
required to revalidate their certification annually. A new cer-
tificate is issued each year, documenting the individual’s
certification status. Certificants who document a minimum
of 1.2 CEUs (12 contact hours) in a calendar year will be
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State Contact
CE, examination, and other
requirements
California http://www.cdph.ca.gov/programs/lfs/Pages/MedicalLaboratory
Technician(MLT).aspx
California State Department of Health Services
Laboratory Field Services
Attn: Personnel Licensing
850 Marina Bay Parkway Bldg P, 1st Floor
Richmond, CA 94804–6403
Tel.: (510) 620–3800; fax: (510) 620–3692
12 contact hours annually;
ASCP BOR or AAB BOR
examinations
Florida http://www.doh.state.fl.us/mqa
Board of Clinical Laboratory Personnel
Division of Medical Quality Assurance
4052 Bald Cypress Way, Bin C07
Tallahassee, FL 32399–3257
Tel.: (850) 245–4355; fax: (850) 922–8876
24 contact hours
biannually
Georgia http://dch.georgia.gov/about-hfr
Georgia Department of Community
Health Healthcare Facility Regulation Division
2 Peachtree Street, NW
Atlanta, GA 30303–3142
Tel.: (404) 657–5450; fax: (404) 657–5442
None
Hawaii http://hawaii.gov/health/laboratories/index_html
Hawaii Department of Health
State Laboratory Division
2725 Waimano Home Road
Pearl City, HI 96782–1496
Tel.: (808) 453–6653; fax: (808) 453–6662
None
Louisiana http://www.lsbme.la.gov
Louisiana State Board of Medical Examiners
Licensure Division
P. O. Box 30250
New Orleans, LA 70190–0250
Tel. (504) 568–6820; fax: (504) 599–0503
12 contact hours annually
Montana http://bsd.dli.mt.gov/license/bsd_boards/cls_board/board_page.asp
Montana Board of Clinical Laboratory Science Practitioners
301 South Park, 4th Floor
P. O. Box 200513
Helena, MT 59620–0513
Tel.: (406) 841–2395; fax: (406) 841–2305
14 contact hours annually
Nevada http://health.nv.gov/HCQC_Medical.htm
Nevada Bureau of Licensure and Certification
1550 East College Parkway Suite 158
Carson City, NV 89716
Tel.: (775) 687–4475; fax: (775) 687–6588
10 contact hours annually
New York http://www.op.nysed.gov/home.html
New York State Education Department
Office of the Professions
Division of Professional Licensing Services
89 Washington Avenue 2nd Floor
Albany, NY 12234–1000
Tel.: (518) 474–3817 ext. 150; fax: (518) 474–4846
None
North Dakota http://www.ndhealth.gov
North Dakota Department of Health
Division of Laboratory Services
P. O. Box 4103 Bismarck, ND 58502–4103
Tel.: (701) 530–1099
20 contact hours
continuing education
biannually
Puerto Rico http://www.ctmpr.com
Puerto Rico Department of Health
Junta Examinadora de Tecnólogos Médicos de
Puerto Rico
Box 10200
Santurce, PR 00908–0200
Tel: (787) 792–6400; fax: (787) 792–6627
36 contact hours
continuing education
every 3 years;
membership in the
Puerto Rico College of
Medical Technologists
Rhode Island http://www.health.state.ri.us
Rhode Island Department of Health
Board of Clinical Laboratory Sciences
3 Capitol Hill, Room 104
Providence, RI 02908–5097
Tel.: (401) 222–5960; fax: (401) 222–6548
30 contact hours
biannually(table continues)
linical L
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played on the individual’s annual certificate.
Licensure
Laboratory directors must possess a current laboratory di-
rector license issued by the State in which the laboratory is
located, if such licensing is required. Twelve states and
Puerto Rico require medical technologists, including tech-
nologists working in molecular diagnostic laboratories, to
obtain a license from their respective state’s Department of
Health (Table 5). The requirements vary from state to state.
Licensure for medical technologists typically requires an
annual or biannual licensing fee, some form of continuing
education, and professional competency requirements, of-
ten in the form of certification from the ASCP or the AAB.
Many states, with the notable exception of California, give
reciprocity for another state’s license. In the remaining 38
states that do not license medical technologists, federal
CLIA 1988 rules apply: to perform high complexity testing,
technologists must have an associate degree or equivalent,
with a major in laboratory science.
Summary
This document provides an update on the routes leading
to certification in molecular pathology that are available to
medical doctors, doctoral-level clinical scientists, and
medical technologists. As the subspecialty of molecular
pathology grows with increased test volume and the in-
troduction of new technologies, formal and accredited
training programs in laboratory medicine for doctoral and
non-doctoral-level clinical scientists will become increas-
ingly important in producing highly trained molecular pa-
thology laboratory professionals. Certification in clinical
molecular diagnostics helps to maintain uniform educa-
tional requirements and ensures that continuing medical
Table 5. Continued
State Contact
Tennessee http://www.health.state.tn.us/Boards/M
Tennessee State Licensure Board
Medical Laboratory Board
227 French Landing, Ste 300
Heritage Place, Metro Center
Nashville, TN 37243–1608
Tel.: (615) 532–3202
West Virginia http://www.wvdhhr.org
West Virginia Department of Health an
Office of Laboratory Science
167 Eleventh Ave
South Charleston, WV 25303–1114
Tel.: (304) 558–3530; fax: (304) 558–2
Initial and licensing fees vary widely; individuals should consult the re
CE, continuing education; CLS, Clinical Laboratory Scientist; CLT, C
nologist; HT, Histotechnologist; PB, phlebotomist.education is sustained. Various routes toward obtainingcertification in molecular diagnostics are available. MGP
certification is available only to medical doctors and re-
quires completion of an ACGME-accredited MGP training
program. Other clinical laboratory scientists can become
certified in molecular pathology by satisfying specific
educational and training requirements. Finally, several
states have licensure requirements for medical technol-
ogists that include certification in molecular diagnostics.
Disclaimer
The Association for Molecular Pathology (AMP) Clinical
Practice Guidelines and Reports are developed to be of
assistance to laboratory and other health care professionals
by providing guidance and recommendations for particular
areas of practice. The Guidelines or Reports should not be
considered inclusive of all proper approaches or methods,
nor exclusive of others. The Guidelines or Reports cannot
guarantee any specific outcome, nor do they define or es-
tablish a standard of care or standard of practice. The
Guidelines or Reports are not intended to dictate the treat-
ment of a particular patient. Treatment decisions must be
made based on the independent judgment of health care
providers and each patient’s individual circumstances.
AMP makes no warranty, express or implied, regarding
the Guidelines or Reports and specifically excludes any
warranties of merchantability and fitness for a particular use
or purpose. AMP shall not be liable for direct, indirect,
special, incidental, or consequential damages related to the
use of the information contained herein.
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